Select Page
Event info
Date:06 Sep
Time:9:00 - 16:00
Venue:Medicon Valley Alliance, Copenhagen
Contact person
Mia Ritterband-Rosenbaum

Mia Ritterband-Rosenbaum

Event Manager & PA to CEO

+45 21 63 38 88

New updates in Drug Formulation & Bioavailability 2022

Welcome to the 10th edition of our event New updates in Drug Formulation & Bioavailability.

This event is based on the concept of synergies between “science” and “business”. Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic.

The presented content and topics will focus on advancements in formulations and cutting edge technologies that can allow cheaper, safer and effective drugs. Pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems.

However, many of the APIs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new and enabling formulation approaches.

Date: September 6th 2022
Time: 9:00 – 16:00
Venue: Medicon Valley Alliance, Edvard Thomsens Vej 14, 2300 København – Auditorium




The meeting will include pre-bookable face-to-face-meetings and will be covered by the media.

Topics will include:

  • Formulation development design space
  • Improving bioavailability of poorly soluble compounds
  • Controlled and modified release technologies
  • Out-sourcing and in-licensing
  • Exploring different routes of administration in enhancing macromolecule delivery

The target audience consists of:

  • Drug formulation professionals from Big Pharma, CDMO’s, Academia
  • Early Phase & virtual biotech and pharma companies
  • QA & Reg Aff. Managers
  • Procurement Managers
  • Speakers will come from: Pharmaceutical companies, Excipient manufacturers, CDMO’s, Academia



8:30 Registration, 1-2-1 partnering meetings and networking at the exhibiton 
09:00 Welcome and introduction
Korbinian Löbmann, University of Copenhagen
09:05 The Viscosity Reduction Platform – Enabling subcutabeous delivery
Tobias Rosenkranz, Merck
09:35 Protein self-assembled materials for drug delivery
Vito Foderá, University of Copenhagen
10:05 Formulation of lipid nanoparticles for drug delivery
Anna Fureby, Director NextBioForm and Senior scientist RI:SE
10:35 Coffee, 1-2-1 partnering meetings and networking at the exhibiton 
11:20 AmorphOXTM – a novel drug delivery platform
Robert Rönn, Orexo
11:50 Improved biopharmaceutical properties for novel oral dosage forms og protein kinase Inhibitiors – a potential new standard of care for chronic myeloid lymphoma
Charlotta Liljebris, Xspray Pharma
12:20 Lunch, 1-2-1 partnering meetings and networking at the exhibiton 
11:30 How to accelerate Scandinavian life science company funding
Johan Kördel, Ph.D. Assoc Prof. Founding
11:50 Research and Drug development – not the same game
Maria Lundberg, CEO SDS Life Science
12:10 Focus on accelerating the growth of the biotech to ensure sustainable future across life science
Bassem Saleh, CEO TFS HealthScience
12:30 Find scientific expertise anywhere in the world 
Francesco Ruospo, CBO AcademicLabs
12:35 Lunch, 1-2-1 partnering meetings and networking at the exhibiton
13:40 What can we learn from drug properties to make sensible decisions about the development of amorphous solid dosage forms? 
Thomas Rades, University of Copenhagen
14:10 Solving the Insoluble – A eutectic approach to enhancing bioavailability  
Niall Hodgins, Seranovo
14:40 New updates in formulation development
Anna Runsjö, Zelmic
15:10 Coffee, 1-2-1 partnering meetings and networking at the exhibiton 
15:40 TBA
Speaker TBA, catalent 
16:10 ICOone Nasal – Novel system for combined nasal and pulmonary drug delivery
Orest Lastow, Iconovo
16:40 Conclusion 
Korbinian Löbmann, University of Copenhagen



To know more about the speakers viste:
Speakers & Papers – New updates in Drug Formulation & Bioavailability 2022 (



Organized by In collaboration with